Login / Signup

SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors.

Sang-Soo KimManish MogheAntonina RaitKathryn DonaldsonJoe B HarfordEsther H Chang
Published in: International journal of nanomedicine (2024)
Collectively, our data suggest that restoring SMARCB1 function via the scL-SMARCB1 nanocomplex may lead to therapeutic benefits in ATRT patients when combined with traditional chemoradiation therapies.
Keyphrases